This is a non-core endpoint: only basic statistics are computed.
Benign neoplasm: Long bones of lower limb
CD2_BENIGN_BONE_LONG_LOWER_EXALLC
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
|
1. Apply sex-specific ruleNone |
- |
2. Check conditionsNone |
|
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
- |
4. Check minimum number of eventsNone |
- |
5. Include endpointsNone |
- |
6. Filter based on genotype QC (FinnGen only)None |
- |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D16
- Name in latin
- Neoplasma benignum ossium longorum membri inferioris
Similar endpoints
↥List of similar endpoints to
Benign neoplasm: Long bones of lower limb
based on the number of shared cases.
Similar with more cases:
- Benign neoplasm: Long bones of lower limb
- Benign neoplasm of bone and articular cartilage
- Benign neoplasm of bone and articular cartilage
- Benign neoplasms
- Benign neoplasms
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
No upset plot: script not run.
No upset table: script not run.
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1246 | 709 | 537 |
| Unadjusted period prevalence (%) | 0.24 | 0.24 | 0.24 |
| Median age at first event (years) | 34.76 | 35.81 | 33.37 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1115
- Matched controls
- 11149
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D16.2
ICD-10 Finland
Benign neoplasm: Long bones of lower limb
+∞
323.0
790
*
21306
ICD-8 Finland
Benign neoplasm of bone and cartilage, Ossium longorum extremitatis inferioris
+∞
202.4
188
*
D48.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bone and articular cartilage
80.1
187.1
209
32
2137A
ICD-9 Finland
Benign neoplasm of bone and articular cartilage, Long bones of lower limb
+∞
168.1
157
*
NGR20
NOMESCO Finland
Intralesional or marginal excision of tumor of knee or lower leg
386.1
107.2
106
*
9102
FHL
Trepanation or removal of the local bone process
52.2
97.6
117
25
NFR20
NOMESCO Finland
Incomplete excision of soft tissue tumour of hip or thigh
126.2
66.7
71
6
NG1CG
NOMESCO Finland
Knee and lower leg extensive MRI examination with high intensity magnet
11.9
62.7
119
111
H02AB02
ATC
dexamethasone; systemic
28.4
52.8
72
27
130
Kela drug reimbursment
Malignant tumour
+∞
50.4
48
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
44.0
42
*
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
3.8
42.1
197
592
C61
ICD-10 Finland
Malignant neoplasm of prostate
152.5
42.1
44
*
115
Kela drug reimbursment
Breast cancer
+∞
39.8
38
*
NK6CT
NOMESCO Finland
Bone biopsy with CT guidance
+∞
39.8
38
*
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
38.8
37
*
NE1CG
NOMESCO Finland
Pelvic, hip and femur extensive MRI examination with high intensity magnet
13.1
38.7
69
56
NF3AA
NOMESCO Finland
Femur X-ray examination
13.2
36.2
64
51
A04AA02
ATC
granisetron; systemic, transdermal
51.5
29.5
35
7
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
29.3
28
*
NK6BN
NOMESCO Finland
Bone dynamic isotope examination
48.5
27.6
33
7
NG1DG
NOMESCO Finland
Knee and lower leg very extensive MRI examination with high intensity magnet
99.2
26.8
29
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
25.1
24
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
25.1
24
*
NHR20
NOMESCO Finland
Incomplete excision of soft tissue tumour of ankle or foot
47.8
23.4
28
6
116
Kela drug reimbursment
Prostate cancer
+∞
23.0
22
*
NFK10
NOMESCO Finland
Fenestration or partial or total excision of bone of femur
85.2
22.7
25
*
HAC20
NOMESCO Finland
Total mastectomy
234.6
22.7
23
*
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
21.9
21
*
NK6AN
NOMESCO Finland
Total body bone isotope imaging
39.5
21.8
27
7
M17.1
ICD-10 Finland
Other primary gonarthrosis
2.3
21.1
213
1024
NG4AA
NOMESCO Finland
Lower leg X-ray examination
5.2
20.9
66
133
NG1BG
NOMESCO Finland
Knee and lower leg MRI examination with high intensity magnet
4.1
20.0
81
211
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
19.8
19
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
+∞
19.8
19
*
D16.3
ICD-10 Finland
Benign neoplasm: Short bones of lower limb
106.9
19.6
21
*
NGK05
NOMESCO Finland
Partial or total excision of bone of lower leg
31.9
19.3
25
8
9101
FHL
Bone biopsy
56.0
19.0
22
*
L03AA13
ATC
pegfilgrastim; parenteral
+∞
18.8
18
*
D16.1
ICD-10 Finland
Benign neoplasm: Short bones of upper limb
30.6
18.4
24
8
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
7.1
18.4
45
66
WX320
NOMESCO Finland
Spinalanesthesy
2.1
18.2
245
1332
JN4BD
NOMESCO Finland
Extensive body CT
4.0
18.1
73
190
WF002
NOMESCO Finland
Radical radiotherapy
53.4
18.0
21
*
L01BC06
ATC
capecitabine; oral
+∞
17.8
17
*
D16.0
ICD-10 Finland
Benign neoplasm: Scapula and long bones of upper limb
42.7
17.3
21
5
C40.22
ICD-10 Finland
Chondrosarcoma of the long bones of the lower extremity
+∞
16.7
16
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
172.4
16.5
17
*
L02BA01
ATC
tamoxifen; oral
30.5
16.1
21
7
A03FA01
ATC
metoclopramide; systemic, rectal
2.4
16.0
152
700
M79.6
ICD-10 Finland
Pain in limb
1.8
15.6
384
2568
NE1DG
NOMESCO Finland
Pelvic, hip and femur very extensive MRI examination with high intensity magnet
22.4
15.6
22
10
NF1AA
NOMESCO Finland
Hip X-ray examination
2.9
15.5
97
352
N03AX16
ATC
pregabalin; oral
1.9
15.2
238
1363
HAB40
NOMESCO Finland
Wedge excision of mammary gland
23.7
15.1
21
9
B01AB05
ATC
enoxaparin; parenteral
1.9
15.1
262
1556
M23.2
ICD-10 Finland
Derangement of meniscus due to old tear or injury
2.4
15.0
133
590
N02AX02
ATC
tramadol; systemic, rectal
1.7
14.9
407
2798
M25.5
ICD-10 Finland
Pain in joint
1.8
14.8
320
2043
C50
ICD-10 Finland
Malignant neoplasm of breast
+∞
14.6
14
*
S18
ICPC
Laceration/cut
1.7
14.5
386
2627
NE1BG
NOMESCO Finland
Pelvic, hip and femur MRI examination with high intensity magnet
4.7
14.3
48
105
N02BE01
ATC
paracetamol; systemic, rectal
1.8
13.9
895
7756
JN4CD
NOMESCO Finland
Very extensive body CT
7.5
13.8
32
44
NFK99
NOMESCO Finland
Other operation on bone of femur
+∞
13.6
13
*
C40.20
ICD-10 Finland
Malignant tumor of the long bones of the lower extremity without histology
+∞
13.6
13
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.7
13.5
381
2626
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
141.6
13.5
14
*
SPAT1153
SPAT
Removal of sutures
1.8
13.2
290
1853
XX3DW
NOMESCO Finland
Time consuming IT work
3.3
13.0
66
209
N02AJ06
ATC
codeine and paracetamol; systemic
1.7
12.9
399
2812
WF003
NOMESCO Finland
Adjuvant radiotherapy
50.6
12.9
15
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
50.6
12.9
15
*
ZZH40
NOMESCO Finland
Substitute of bone
9.2
12.8
26
29
WX408
NOMESCO Finland
General anesthesy, balanced
1.8
12.7
261
1629
NG1AD
NOMESCO Finland
Knee CT examination
7.1
12.6
30
43
A04AA55
ATC
palonosetron, combinations; systemic
+∞
12.5
12
*
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
+∞
12.5
12
*
C50.99
ICD-10 Finland
Breast, unspecified
+∞
12.5
12
*
Q78.6
ICD-10 Finland
Multiple congenital exostoses
131.4
12.5
13
*
D48.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Connective and other soft tissue
5.6
12.3
35
64
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.6
11.9
470
3513
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
47.2
11.9
14
*
9220/3-C40.2
ICD-O-3
Chondrosarcoma, NOS, of long bones of lower limb and associated joints
+∞
11.5
11
*
KEC01
NOMESCO Finland
Percutaneous endoscopic radical prostatectomy
+∞
11.5
11
*
M01AE01
ATC
ibuprofen; systemic, rectal
1.9
11.5
991
9010
NGR30
NOMESCO Finland
Extensive or radikal excision of tumor of knee or lower leg
121.2
11.4
12
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
121.2
11.4
12
*
M85.4
ICD-10 Finland
Solitary bone cyst
35.4
11.3
14
*
L02AE02
ATC
leuprorelin; implant, parenteral
7.7
11.2
25
33
9103
FHL
Partial or complete bone removal
20.3
11.1
16
8
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.7
11.0
302
2043
NJ2MA
NOMESCO Finland
Measurement of mechanical axis of lower leg with X-ray
2.7
10.9
72
273
JN4AD
NOMESCO Finland
Body CT examination
4.0
10.8
42
108
ZX070
NOMESCO Finland
Intensity modified radiotherapy
60.6
10.6
12
*
NFR30
NOMESCO Finland
Extended excision of soft tissue tumour of hip or thigh
+∞
10.4
10
*
KE3AT
NOMESCO Finland
Transrectal gold marker implantation in prostate under ultrasound guidance
+∞
10.4
10
*
C50.11
ICD-10 Finland
Malignant tumor of the central part of the mammary gland,ductal tumor
+∞
10.4
10
*
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
10.4
10
*
B01AB10
ATC
tinzaparin; parenteral
3.3
10.1
50
157
KE1AT
NOMESCO Finland
Biopsy of prostata with ultrasoudnguidance
5.6
10.0
28
51
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.6
9.9
265
1773
UKC02
NOMESCO Finland
Cystoscopy
2.1
9.9
120
617
N02AA05
ATC
oxycodone; systemic
2.3
9.9
95
440
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.8
9.8
187
1132
Z51.5
ICD-10 Finland
Palliative care
5.9
9.7
26
45
M01AH05
ATC
etoricoxib; oral
1.5
9.7
604
4928
ZXA00
NOMESCO Finland
Right side
1.7
9.7
228
1471
D16.8
ICD-10 Finland
Benign neoplasm: Pelvic bones, sacrum and coccyx
55.5
9.7
11
*
M12.2
ICD-10 Finland
Villonodular synovitis (pigmented)
55.5
9.7
11
*
ZXA05
NOMESCO Finland
Left side
1.7
9.6
226
1456
L02BG04
ATC
letrozole; oral
4.4
9.6
33
76
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
2.3
9.6
91
421
M23.9
ICD-10 Finland
Internal derangement of knee, unspecified
2.2
9.5
102
497
NGA20
NOMESCO Finland
Exploration of soft tissue knee or lower leg, open
30.3
9.4
12
*
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.6
9.4
275
1882
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.7
9.4
234
1531
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
9.4
9
*
C50.21
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor
+∞
9.4
9
*
Y77
ICPC
Malignant neoplasm prostate
+∞
9.4
9
*
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
+∞
9.4
9
*
X76
ICPC
Malignant neoplasm breast female
+∞
9.4
9
*
R22.4
ICD-10 Finland
Localized swelling, mass and lump, lower limb
4.5
9.4
32
73
9104
FHL
Autogenous bone graft
21.9
9.4
13
6
M16.1
ICD-10 Finland
Other primary coxarthrosis
2.2
9.3
91
425
NF3BA
NOMESCO Finland
Femur extensive X-ray examination
37.0
9.0
11
*
A02BC02
ATC
pantoprazole; systemic
1.5
8.9
604
4974
M01AE02
ATC
naproxen; oral, rectal
1.5
8.8
595
4893
A04AA01
ATC
ondansetron; systemic, rectal
3.6
8.8
38
108
D21.2
ICD-10 Finland
Benign neoplasm: Connective and other soft tissue of lower limb, including hip
14.2
8.7
14
10
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
50.4
8.7
10
*
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
50.4
8.7
10
*
NFU20
NOMESCO Finland
Removal of internal fixation device from femur
7.7
8.7
19
25
N06AX21
ATC
duloxetine; oral
1.9
8.6
124
679
M54.5
ICD-10 Finland
Low back pain
1.5
8.5
339
2493
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
90.7
8.4
9
*
C73.91
ICD-10 Finland
Papillary carcinoma of the thyroid gland (thyroid gland)
+∞
8.3
8
*
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
+∞
8.3
8
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
8.3
8
*
C50.51
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor
+∞
8.3
8
*
C40.2
ICD-10 Finland
Malignant neoplasm: Long bones of lower limb
+∞
8.3
8
*
C50.81
ICD-10 Finland
Overall malignant tumor of the mammary gland, ductal tumor
+∞
8.3
8
*
D48.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Neoplasm of uncertain or unknown behaviour, unspecified
6.1
8.2
21
35
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
33.6
8.1
10
*
L03AA02
ATC
filgrastim; parenteral
33.6
8.1
10
*
NE1AD
NOMESCO Finland
Pelvis and hip bones CT examination
5.1
8.1
24
48
HA1AA
NOMESCO Finland
X-ray mammography
3.4
7.9
36
108
L15
ICPC
Knee symptom/complaint
1.6
7.8
200
1315
N03AX12
ATC
gabapentin; oral
1.8
7.8
147
883
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.7
7.7
169
1065
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.9
7.6
114
636
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
3.1
7.5
39
129
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
2.1
7.4
86
436
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
2.7
7.4
47
176
9180/3-C40.2
ICD-O-3
Osteosarcoma, NOS, of long bones of lower limb and associated joints
+∞
7.3
7
*
C40.21
ICD-10 Finland
Osteosarcoma of the long bones of the lower extremity
+∞
7.3
7
*
C40.29
ICD-10 Finland
Malignant tumor of the long bones of the lower extremity other or unspecified histology
+∞
7.3
7
*
WB203
NOMESCO Finland
Simple adjuvant hormone therapy of malignancy
+∞
7.3
7
*
8500/3-C50.4
ICD-O-3
Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast
+∞
7.3
7
*
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
+∞
7.3
7
*
M89.3
ICD-10 Finland
Hypertrophy of bone
+∞
7.3
7
*
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
+∞
7.3
7
*
8140/3-C20.9
ICD-O-3
Adenocarcinoma, NOS, of rectum, NOS
+∞
7.3
7
*
NGR99
NOMESCO Finland
Other operation for tumour of knee or lower leg
+∞
7.3
7
*
L02BB03
ATC
bicalutamide; oral
+∞
7.3
7
*
J01DB01
ATC
cefalexin; oral
1.5
7.2
852
7657
M01AB05
ATC
diclofenac; systemic, rectal
1.4
7.2
668
5731
X58
ICD-10 Finland
Exposure to other specified factors
1.7
7.2
153
956
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.7
7.1
156
983
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.5
7.1
230
1602
R50.9
ICD-10 Finland
Fever, unspecified
1.8
7.0
120
701
ZZH31
NOMESCO Finland
Bone allograft, small pieces
7.6
6.9
15
20
M02AA07
ATC
piroxicam; topical
1.5
6.9
311
2328
L13
ICPC
Hip symptom/complaint
1.8
6.9
123
729
J01AA02
ATC
doxycycline; systemic
1.4
6.9
767
6777
AA1AD
NOMESCO Finland
CT of head and brain
1.6
6.8
190
1276
SPAT1312
SPAT
General health counselling
1.4
6.7
327
2482
NGD05
NOMESCO Finland
Partial excision of meniscus of knee, arthroscopic
1.8
6.6
110
639
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.4
6.6
354
2740
XKD00
NOMESCO Finland
Uroflowmetry
1.9
6.5
98
549
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
5.4
6.5
18
34
NFR99
NOMESCO Finland
Other operation for tumour of hip or thigh
70.2
6.4
7
*
NJ3DG
NOMESCO Finland
Very extensive MRI examination of extremities with high intensity magnet
70.2
6.4
7
*
NK6DT
NOMESCO Finland
Bone biopsy with MRI guidance
70.2
6.4
7
*
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
2.3
6.4
57
256
PJ5AN
NOMESCO Finland
Localisation of sentinell lymphnode with isotope imaging
+∞
6.3
6
*
L02BX02
ATC
degarelix; parenteral
+∞
6.3
6
*
C50.42
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor
+∞
6.3
6
*
8130/2-C67.9
ICD-O-3
Papillary urothelial carcinoma, non-invasive of bladder, NOS
+∞
6.3
6
*
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
6.3
6
*
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
6.3
6
*
8260/3-C73.9
ICD-O-3
Papillary adenocarcinoma, NOS, of thyroid gland
+∞
6.3
6
*
C50.91
ICD-10 Finland
Malignant tumor in another specified localization in ductal mammary gland
+∞
6.3
6
*
L16
ICPC
Ankle symptom/complaint
1.8
6.2
100
573
D16.90
ICD-10 Finland
Bone and articular cartilage, unspecified
26.8
6.2
8
*
NFA20
NOMESCO Finland
Exploration of hip joint or femur
26.8
6.2
8
*
THW99
NOMESCO Finland
Other minor procedure in surgery of mammary gland
26.8
6.2
8
*
M17.0
ICD-10 Finland
Primary gonarthrosis, bilateral
1.8
6.2
96
543
NH1BG
NOMESCO Finland
Ankle and foot MRI examination with high intensity magnet
3.5
6.0
26
76
NG4AD
NOMESCO Finland
Lower leg CT
10.1
6.0
11
11
D40.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Prostate
10.1
6.0
11
11
NH3BA
NOMESCO Finland
Foot and toes extensive X-ray examination
2.5
6.0
43
174
Z47.8
ICD-10 Finland
Other specified orthopaedic follow-up care
6.1
6.0
15
25
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
116
367
3.38
30.06
3.6
1.6
38.2
3.4
ug/l
0.50
93
276
574
4130
1.72
19.16
3.9
3.6
—
—
—
0
0
854
6985
1.71
16.57
8.1
5.4
78.6
73.5
u/l
2.60
802
6526
316
1993
1.78
16.29
2.3
2.0
—
—
—
0
0
576
4323
1.62
15.15
6.2
4.0
11.0
11.3
umol/l
0.19
543
4059
542
4020
1.62
14.88
7.9
5.6
1.2
1.2
mmol/l
0.20
445
3452
473
3436
1.61
13.89
4.9
4.0
36.4
36.6
g/l
0.52
426
3197
491
3605
1.60
13.76
7.1
5.3
1.2
1.2
mmol/l
0.18
434
3250
854
7253
1.56
11.72
4.6
3.8
9.8
10.0
mm/h
0.18
788
6744
124
653
2.00
10.96
2.8
2.3
0.2
0.2
g/l
0.20
118
596
651
5280
1.49
10.61
4.9
4.3
6.5
6.6
mmol/l
0.32
610
4861
364
2616
1.55
10.59
3.0
2.0
2.3
2.4
mmol/l
0.09
318
2258
727
6068
1.48
9.99
4.6
3.8
117.3
1933.4
e6/l
—
6
79
128
711
1.89
9.67
4.2
3.2
233.5
233.3
u/l
0.01
123
667
182
1126
1.72
9.61
4.0
4.1
31.9
31.6
%
0.11
123
789
1105
10160
1.77
9.37
14.3
10.5
20.6
21.0
mg/l
0.16
883
7731
172
1092
1.67
8.21
7.3
5.6
—
—
—
0
0
633
5267
1.41
8.10
9.7
6.8
4.0
4.1
e9/l
1.02
563
4616
50
208
2.46
7.91
1.4
1.7
20349.4
9624.9
e6/l
0.72
39
157
41
156
2.68
7.77
3.2
2.3
870.3
86.5
u/ml
0.69
33
125
51
227
2.30
6.98
1.4
1.4
—
—
—
0
0
364
2815
1.41
6.80
2.6
2.4
54.3
56.8
u/l
0.76
328
2610
347
2677
1.41
6.54
2.3
2.1
275.5
212.9
u/l
0.25
332
2518
18
47
3.87
6.27
2.3
1.8
—
—
—
0
0
92
532
1.79
6.14
2.2
1.5
67.3
68.0
g/l
0.51
85
488
173
1181
1.54
6.06
4.6
2.9
0.8
0.8
mmol/l
0.15
159
1105
154
1034
1.56
5.81
6.6
5.5
1.0
1.0
mmol/l
0.00
146
957
14
32
4.41
5.77
3.4
1.9
81.5
66.3
ug/l
0.22
14
32
307
2375
1.39
5.57
2.8
2.2
2154.3
5358.1
umol/l
0.93
274
2110
34
145
2.38
5.19
1.6
1.6
—
—
—
0
0
173
1221
1.48
5.17
1.7
1.7
—
—
—
0
0
1087
10238
1.48
5.10
16.0
11.6
139.7
139.7
mmol/l
0.23
1055
9954
405
3310
1.33
5.09
3.2
3.1
22.4
45.0
ng/l
2.52
252
1962
1088
10274
1.47
4.78
16.0
11.7
3.9
4.0
mmol/l
0.45
1053
9970
32
146
2.22
4.24
1.8
1.6
—
—
—
0
0
93
600
1.59
4.20
3.4
4.0
70.5
83.8
ng/l
0.88
84
542
43
221
1.98
4.20
1.5
1.4
248.2
320.6
ug/g
1.43
24
127
42
215
1.99
4.15
2.6
3.1
—
—
—
0
0
859
7883
1.29
4.09
4.1
3.8
14.7
14.6
pmol/l
1.27
785
7272
16
52
3.10
4.09
2.3
1.8
14.8
13.4
%
—
8
32
25
104
2.43
4.07
1.4
1.2
—
—
—
0
0
51
281
1.85
4.06
1.4
1.7
—
—
—
0
0
1008
9470
1.34
3.92
12.3
9.0
88.2
87.4
ml/min/173m2
0.55
845
7563
87
562
1.59
3.92
4.3
2.4
1.2
1.2
mmol/l
0.87
74
466
21
82
2.59
3.89
1.2
1.4
15062.0
202170.2
e6/l
0.97
11
61
168
1249
1.40
3.80
1.9
2.0
30.2
29.5
s
0.46
159
1206
68
417
1.67
3.78
1.6
1.6
—
—
—
0
0
8
12
6.70
3.67
1.9
1.9
—
—
—
0
0
39
205
1.93
3.61
1.7
1.6
—
—
—
0
0
780
7129
1.25
3.56
3.6
2.9
47.4
42.3
u/l
1.03
723
6752
280
2276
1.30
3.49
3.2
2.7
0.3
0.3
e6/l
0.03
220
1698
117
828
1.46
3.48
10.2
8.6
1.2
1.3
mmol/l
0.09
95
649
23
100
2.32
3.44
1.3
1.2
—
—
—
0
0
546
4811
1.24
3.43
3.8
3.1
0.0
0.0
estimate
0.80
101
799
23
101
2.30
3.37
1.3
1.2
—
—
—
0
0
23
101
2.30
3.37
1.3
1.2
—
—
—
0
0
117
834
1.44
3.35
10.3
8.5
5.1
5.1
kpa
0.36
110
801
117
834
1.44
3.35
10.2
8.5
12.6
11.9
kpa
0.75
110
802
49
286
1.74
3.29
2.1
2.5
577.9
331.4
ug/l
0.26
44
265
23
103
2.26
3.23
1.6
1.6
48.3
58.9
%
0.59
16
73
221
1758
1.31
3.22
1.4
1.3
7.4
10.7
u/ml
0.55
92
706
52
311
1.70
3.21
1.7
1.8
—
—
—
0
0
219
1741
1.31
3.21
2.6
2.3
6.8
7.0
e6/l
0.06
194
1528
87
591
1.51
3.18
3.0
3.2
4.5
4.6
pmol/l
0.38
75
520
538
4761
1.23
3.18
4.9
4.3
0.0
0.0
estimate
0.50
101
840
538
4761
1.23
3.18
3.8
3.1
0.0
0.0
estimate
0.00
99
815
448
3890
1.24
3.16
2.7
2.3
77.3
74.8
nmol/l
0.72
401
3539
100
700
1.47
3.16
2.3
2.1
75.2
73.9
ml/min/173m2
0.12
51
268
260
2122
1.28
3.12
2.8
2.9
1126.0
1019.0
ng/l
0.14
214
1753
56
345
1.65
3.10
2.1
2.0
—
—
—
0
0
174
1345
1.34
3.09
2.9
1.9
2.4
2.4
mmol/l
2.16
154
1161
6
8
7.53
3.05
1.3
1.1
—
—
—
0
0
42
240
1.78
3.05
2.0
1.8
1.1
1.1
ug/l
0.01
35
216
67
438
1.56
2.93
1.8
2.0
39.4
39.3
u/l
0.02
59
392
296
2478
1.26
2.87
4.4
3.4
0.0
0.0
estimate
1.08
98
825
22
103
2.16
2.81
1.3
1.2
—
—
—
0
0
115
847
1.39
2.78
1.7
1.7
—
—
—
0
0
106
771
1.41
2.76
3.4
2.7
—
—
—
0
0
22
104
2.14
2.75
1.3
1.2
—
—
—
0
0
22
104
2.14
2.75
1.3
1.2
—
—
—
0
0
7
14
5.02
2.73
1.9
1.3
—
—
—
0
0
19
85
2.25
2.71
1.1
1.1
—
—
—
0
0
109
800
1.40
2.70
2.2
2.3
13.6
13.9
nmol/l
0.14
98
720
137
1051
1.34
2.58
2.5
2.5
25.1
24.7
%
0.09
117
897
18
81
2.24
2.54
1.1
1.2
57.4
56.9
u/l
—
8
55
14
56
2.52
2.53
2.2
2.0
467.4
551.0
e6/l
—
9
47
114
854
1.37
2.51
1.7
1.7
—
—
—
0
0
225
1852
1.26
2.51
1.4
1.3
22.2
29.7
iu/ml
0.73
76
583
422
3714
1.21
2.49
4.1
3.2
—
—
—
0
0
222
1833
1.26
2.41
1.7
1.6
412.8
34118816.7
pmol/l
1.92
183
1571
16
71
2.27
2.35
1.3
1.5
—
—
—
0
0
9
28
3.23
2.31
1.2
1.3
—
—
—
0
0
9
28
3.23
2.31
1.2
1.3
—
—
—
0
0
45
285
1.60
2.31
1.4
1.2
3.7
8.7
u/ml
—
8
49
16
72
2.24
2.28
1.4
1.1
—
2.2
—
0
5
148
1170
1.30
2.28
2.4
2.3
2.4
2.4
g/l
0.41
139
1084
8
23
3.49
2.27
1.3
1.3
—
—
—
0
0
8
23
3.49
2.27
1.3
1.3
—
—
—
0
0
816
7654
1.19
2.27
3.4
3.3
—
—
—
0
0
29
164
1.79
2.24
1.6
1.3
—
1.1
—
0
20
9
29
3.12
2.22
2.1
2.3
—
—
—
0
0
127
987
1.32
2.22
20.1
20.2
1.3
1.3
inr
0.08
16
151
23
121
1.92
2.21
1.0
1.3
—
—
—
0
0
126
979
1.32
2.20
3.0
2.4
5.9
7.3
umol/l
0.61
108
840
257
2179
1.23
2.19
1.9
1.8
1.1
0.9
mg/l
0.66
198
1594
47
305
1.56
2.19
1.4
1.3
—
—
—
0
0
159
1278
1.28
2.16
2.9
2.6
2.5
2.6
e6/l
0.09
93
657
76
548
1.41
2.13
2.5
2.3
3702.3
3678.5
u/l
0.00
22
233
169
1372
1.27
2.12
2.8
2.4
0.8
1.0
e6/l
0.63
100
750
28
161
1.76
2.07
5.5
5.3
1511.8
544.8
iu/ml
—
5
22
29
169
1.73
2.05
1.6
1.3
60.4
30.0
mg/l
0.60
23
132
29
169
1.73
2.05
1.6
1.3
31.5
40.9
mg/l
0.44
23
133
317
2761
1.20
2.05
4.7
3.2
1.9
1.7
ug/l
0.48
287
2507
6
15
4.01
2.04
1.2
1.1
5.1
6.4
nmol/l
—
6
15
16
76
2.12
2.03
1.3
1.3
—
—
—
0
0
32
193
1.68
2.01
1.3
1.2
—
—
—
0
0
186
1538
1.25
2.00
1.7
1.8
1.5
1.4
%
0.12
159
1383
287
2486
1.20
1.96
1.3
1.3
0.8
1.7
u/ml
2.48
76
687
20
105
1.92
1.96
1.3
1.9
23.5
21.4
nmol/l
0.21
20
96
43
282
1.54
1.94
1.4
1.2
2.8
2.7
u/ml
—
5
31
230
1954
1.22
1.92
1.5
1.5
19.9
21.0
nmol/l
0.56
191
1693
165
1353
1.25
1.92
2.3
2.5
88.0
114.0
ug/g
0.58
126
1070
503
4577
1.17
1.91
2.8
2.7
113.7
100.4
ug/l
0.83
473
4276
76
560
1.38
1.90
1.6
1.4
22.0
24.3
iu/l
0.25
67
471
202
1697
1.23
1.88
3.0
3.4
485.0
553.2
ng/l
0.08
129
1178
402
3598
1.17
1.87
1.9
1.8
103.1
96.3
pmol/l
1.53
213
1909
978
9381
1.20
1.87
5.0
4.5
1.8
2.0
mu/l
0.99
899
8734
18
93
1.95
1.85
1.1
1.2
27.4
36.7
mg/l
1.32
18
73
1190
11682
1.42
1.79
21.7
15.4
136.5
138.2
g/l
4.25
1178
11518
1188
11662
1.40
1.75
21.8
15.3
256.7
254.9
e9/l
0.46
1167
11374
17
88
1.94
1.75
1.0
1.1
225.8
244.6
mg/l
0.29
17
77
112
887
1.29
1.74
2.1
1.9
346.3
370.5
nmol/l
0.75
102
821
43
291
1.49
1.71
1.2
1.1
—
—
—
0
0
1189
11677
1.40
1.71
21.7
15.3
4.5
4.6
e12/l
3.60
1167
11370
358
3196
1.17
1.71
3.4
2.8
33.1
31.3
u/l
0.39
345
3040
1189
11681
1.39
1.66
21.7
15.3
6.7
6.6
e9/l
0.53
1166
11370
155
1284
1.24
1.66
2.4
2.4
15.1
14.4
umol/l
0.54
147
1177
193
1640
1.21
1.62
2.2
2.1
—
—
—
0
0
1013
9789
1.19
1.58
4.5
4.0
5.8
5.8
mmol/l
0.29
919
9069
43
297
1.46
1.57
7.0
6.2
2.5
1.6
%
0.66
38
282
12
57
2.12
1.55
1.1
1.0
—
—
—
0
0
68
512
1.35
1.53
1.5
1.5
—
—
—
0
0
104
834
1.27
1.50
2.7
2.3
36.4
96.0
u/l
0.52
86
708
99
790
1.28
1.48
1.3
1.2
93.6
144.8
iu/ml
1.17
40
334
10
45
2.23
1.46
1.4
2.8
795.8
697.4
u/ml
—
10
45
949
9143
1.16
1.44
5.7
5.1
38.7
39.1
mmol/mol
0.73
881
8604
23
141
1.64
1.42
2.4
2.2
17.1
16.9
%
0.09
16
75
44
313
1.42
1.41
2.5
1.7
0.2
0.2
g/l
0.78
39
295
5
17
2.95
1.36
1.0
1.2
116.8
106.2
%
—
5
17
5
17
2.95
1.36
1.0
1.2
—
—
—
0
0
14
75
1.88
1.34
1.1
1.4
—
—
—
0
0
1117
10927
1.21
1.31
11.4
8.1
28.4
27.4
u/l
0.87
1079
10570
16
91
1.77
1.29
1.3
1.4
—
—
—
0
0
201
1753
1.17
1.28
1.4
1.5
—
—
—
0
0
67
520
1.30
1.27
4.4
3.2
1.8
1.7
mmol/l
0.07
56
377
26
170
1.54
1.26
1.8
3.3
33.8
34.1
umol/l
0.02
21
154
24
154
1.57
1.26
1.5
2.0
—
1984.0
—
0
5
41
295
1.40
1.25
1.8
2.4
91.5
92.9
%
0.16
41
277
14
77
1.83
1.25
1.5
1.5
—
—
—
0
0
19
115
1.66
1.25
1.5
1.2
—
—
—
0
0
77
614
1.27
1.20
1.1
1.0
—
—
—
0
0
13
71
1.84
1.19
2.2
2.0
—
—
—
0
0
26
173
1.51
1.18
2.3
2.2
133.9
133.9
g/l
0.00
21
133
54
412
1.32
1.17
1.5
1.5
—
—
—
0
0
205
1807
1.16
1.16
2.3
2.2
—
—
—
0
0
13
220
0.59
1.11
1.4
1.6
—
—
—
0
0
168
1463
1.17
1.11
1.8
1.7
1135.9
1149.7
nmol/l
0.07
124
1134
65
514
1.28
1.10
1.5
1.4
—
—
—
0
0
35
252
1.40
1.09
1.1
1.1
1.2
2.1
u/ml
0.43
13
115
36
263
1.38
1.04
1.8
2.2
10.6
11.1
mg/l
0.17
36
242
9
46
1.96
1.03
1.8
1.6
—
—
—
0
0
7
34
2.06
1.03
2.0
1.9
—
—
—
0
0
7
34
2.06
1.03
2.0
1.9
—
—
—
0
0
7
35
2.01
1.00
1.4
1.4
10.3
8.3
ug/l
—
7
35
17
107
1.60
1.00
1.4
1.1
—
—
—
0
0
75
612
1.24
1.00
3.5
2.7
4.8
4.7
kpa
0.18
75
592
24
164
1.47
0.99
2.8
2.2
5.7
4.4
umol/l
0.50
14
119
320
2939
1.12
0.98
3.7
3.2
8.1
8.2
mmol/l
0.13
270
2536
5
23
2.18
0.98
1.8
2.4
—
—
—
0
0
49
381
1.30
0.96
1.8
1.8
—
—
—
0
0
26
182
1.44
0.96
1.3
1.2
—
—
—
0
0
6
27
2.23
0.93
1.8
1.2
—
—
—
0
0
6
27
2.23
0.93
1.8
1.2
—
—
—
0
0
6
27
2.23
0.93
1.8
1.2
—
—
—
0
0
12
70
1.72
0.92
1.1
1.3
1.7
1.9
mmol/l
0.45
12
70
11
63
1.75
0.90
1.8
2.0
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
26
185
1.41
0.90
3.7
4.1
0.4
0.4
u/ml
0.22
17
106
28
202
1.40
0.89
1.4
1.4
—
10.2
—
0
5
47
368
1.29
0.89
1.6
1.4
8.3
8.6
u/l
0.07
39
307
34
254
1.35
0.89
1.3
1.3
3.6
3.9
g/l
0.62
20
190
34
254
1.35
0.89
1.3
1.3
—
—
—
0
0
34
254
1.35
0.89
1.3
1.3
7.2
7.4
g/l
0.16
23
200
176
1568
1.14
0.88
2.9
2.4
0.7
0.7
ug/l
0.04
106
886
15
229
0.65
0.88
2.9
2.3
128.7
129.1
ug/min
—
9
141
1008
9852
1.12
0.86
14.8
11.3
40.4
40.8
%
0.83
750
7663
19
128
1.49
0.86
1.1
1.1
—
—
—
0
0
30
221
1.37
0.86
1.8
2.4
1.0
0.8
nmol/l
0.39
24
190
31
231
1.35
0.83
1.3
1.3
9.9
10.8
g/l
0.52
25
199
241
2203
1.12
0.81
4.3
3.1
21.1
23.1
%
1.12
104
844
0
24
0.00
0.79
0.0
1.5
—
—
—
0
0
24
173
1.39
0.79
3.1
3.7
57.0
56.2
%
0.12
24
173
14
90
1.56
0.78
1.1
1.1
—
—
—
0
0
17
115
1.48
0.77
1.1
1.1
—
—
—
0
0
23
166
1.39
0.76
1.1
1.1
—
—
—
0
0
11
67
1.65
0.75
1.1
1.1
3.2
8.5
iu/ml
—
5
16
7
38
1.85
0.73
1.0
1.3
—
—
—
0
0
12
76
1.58
0.71
2.0
1.8
32.6
33.2
pg
0.12
12
76
23
168
1.38
0.71
1.2
1.2
2.1
6.9
u/ml
1.83
14
73
32
247
1.30
0.71
1.1
1.3
2.9
3.0
g/l
0.41
23
194
85
732
1.17
0.70
3.8
3.4
5.9
5.9
kpa
0.10
85
708
17
118
1.45
0.69
1.4
1.4
—
—
—
0
0
84
727
1.17
0.66
3.8
3.5
2.1
2.0
mmol/l
0.17
72
578
23
171
1.35
0.66
2.9
3.5
4.0
4.1
e9/l
0.07
23
171
240
2227
1.10
0.62
2.2
2.1
2.9
2.8
mg/l
0.29
204
1896
11
71
1.55
0.62
1.7
1.4
—
—
—
0
0
8
49
1.64
0.62
1.1
1.1
1659.3
1606.6
miu/ml
—
8
49
10
63
1.59
0.62
1.5
2.1
421.4
905.8
e6/l
—
5
21
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
8
50
1.60
0.61
1.0
1.2
—
—
—
0
0
993
9749
1.09
0.60
4.0
3.7
1.3
1.3
mmol/l
1.16
913
9134
1048
10314
1.10
0.60
4.7
4.4
2.8
2.8
mmol/l
0.01
966
9686
0
20
0.00
0.60
0.0
1.4
—
—
—
0
0
10
64
1.57
0.58
1.3
1.2
—
—
—
0
0
20
149
1.35
0.58
1.3
1.3
—
—
—
0
0
20
149
1.35
0.58
1.3
1.3
—
—
—
0
0
61
710
0.85
0.57
1.6
1.5
—
—
—
0
0
41
338
1.22
0.56
1.6
1.6
0.1
0.1
iu/ml
0.28
11
57
44
366
1.21
0.56
1.3
1.5
—
—
—
0
0
11
74
1.49
0.53
1.2
1.1
—
—
—
0
0
250
2343
1.08
0.53
1.6
1.6
—
—
—
0
0
6
39
1.54
0.53
1.8
1.2
—
—
—
0
0
6
39
1.54
0.53
1.8
1.2
—
—
—
0
0
6
39
1.54
0.53
1.8
1.2
—
—
—
0
0
6
39
1.54
0.53
1.8
1.2
—
—
—
0
0
24
187
1.29
0.53
1.5
1.4
106.6
101.4
u/ml
—
7
40
234
2188
1.09
0.52
4.0
3.4
1.0
1.0
kg/l
0.64
31
290
6
40
1.50
0.51
1.2
1.5
29.5
28.3
umol/l
—
6
40
23
179
1.29
0.51
1.7
1.4
0.3
0.4
nmol/l
0.95
17
158
285
2690
1.08
0.51
4.0
4.0
6.0
9.3
mg/mmol
1.25
179
1731
6
41
1.47
0.50
4.5
1.5
209.0
191.5
u/l
—
6
41
81
718
1.14
0.50
2.0
2.3
5.7
7.4
ug/l
0.60
69
641
24
301
0.79
0.49
2.0
1.7
—
—
—
0
0
91
815
1.13
0.48
1.6
1.9
—
—
—
0
0
7
46
1.52
0.48
1.0
1.3
—
—
—
0
0
57
494
1.16
0.48
2.0
1.9
—
—
—
0
0
42
495
0.84
0.48
1.7
1.7
4.4
3.3
mg/l
0.38
31
338
71
626
1.14
0.48
2.5
3.0
169.1
162.8
ng/l
0.05
62
571
113
1241
0.90
0.47
1.8
1.7
—
—
—
0
0
11
77
1.43
0.45
1.0
1.1
—
—
—
0
0
7
50
1.40
0.45
1.7
1.9
1.8
6.5
nmol/l
—
7
40
7
50
1.40
0.45
1.0
1.1
—
—
—
0
0
20
157
1.28
0.43
1.4
1.2
16.5
18.0
u/l
0.12
20
136
40
467
0.85
0.42
1.5
1.4
—
—
—
0
0
5
32
1.56
0.42
1.2
1.8
11.4
17.9
umol/l
—
5
32
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
0
17
0.00
0.40
0.0
1.0
—
—
—
0
0
0
17
0.00
0.40
0.0
1.1
—
—
—
0
0
1025
10122
1.07
0.40
4.3
4.0
1.4
1.4
mmol/l
0.33
944
9514
0
18
0.00
0.40
0.0
1.7
—
1.2
—
0
18
0
18
0.00
0.40
0.0
2.5
—
0.9
—
0
18
26
216
1.21
0.37
1.5
1.2
184.6
233.1
u/ml
0.62
19
131
11
81
1.36
0.36
1.7
1.4
—
—
—
0
0
21
171
1.23
0.36
1.3
1.4
27.1
19.8
u/l
0.30
14
138
5
77
0.65
0.35
3.0
3.9
—
—
—
0
0
6
42
1.43
0.35
1.8
1.7
—
—
—
0
0
6
44
1.37
0.34
1.0
2.2
15.1
204.9
ug/l
—
6
38
1029
10182
1.06
0.33
4.4
4.1
4.7
4.7
mmol/l
0.17
953
9610
35
402
0.87
0.32
1.3
1.5
—
—
—
0
0
7
55
1.27
0.30
1.0
1.1
869.8
243.7
iu/ml
—
7
55
7
57
1.23
0.29
1.7
1.6
—
—
—
0
0
27
232
1.17
0.28
1.4
1.2
—
—
—
0
0
31
270
1.15
0.28
1.7
2.0
5.3
4.9
iu/l
—
10
103
108
1014
1.07
0.26
1.7
1.9
—
—
—
0
0
11
138
0.80
0.25
1.1
1.1
—
—
—
0
0
18
151
1.19
0.25
1.1
1.1
—
—
—
0
0
21
179
1.18
0.25
1.1
1.1
9.3
100.9
iu/ml
—
9
46
9
77
1.17
0.24
1.2
1.6
—
—
—
0
0
5
40
1.25
0.22
1.0
1.0
—
—
—
0
0
33
367
0.90
0.21
1.4
1.4
—
—
—
0
0
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
40
363
1.11
0.21
1.6
1.8
—
—
—
0
0
5
43
1.16
0.21
1.2
1.1
—
—
—
0
0
33
366
0.90
0.20
1.3
1.4
—
—
—
0
0
33
366
0.90
0.20
1.3
1.4
—
—
—
0
0
14
117
1.20
0.20
1.6
1.5
—
—
—
0
0
6
48
1.25
0.20
1.0
1.6
—
—
—
0
0
33
365
0.90
0.20
1.3
1.4
—
—
—
0
0
9
114
0.79
0.20
1.9
1.4
—
—
—
0
0
11
90
1.22
0.19
1.2
1.6
—
—
—
0
0
24
270
0.89
0.19
1.7
1.5
—
—
—
0
0
6
52
1.15
0.19
1.0
1.6
—
—
—
0
0
31
342
0.90
0.18
1.6
1.6
—
—
—
0
0
40
367
1.09
0.18
2.6
3.1
25.4
25.2
mmol/l
0.21
40
352
34
372
0.91
0.17
1.1
1.4
—
—
—
0
0
78
742
1.05
0.15
1.4
1.3
154.9
251.7
u/ml
1.14
72
691
31
285
1.09
0.14
6.7
3.8
1.4
1.4
mmol/l
0.15
31
278
19
170
1.12
0.13
1.9
1.5
—
—
—
0
0
60
631
0.95
0.12
1.5
1.3
—
—
—
0
0
258
2633
0.97
0.12
1.6
1.7
1.3
1.4
mmol/l
0.74
226
2276
5
45
1.11
0.10
1.2
1.0
—
—
—
0
0
5
46
1.09
0.09
1.0
1.2
—
77.6
—
0
5
6
58
1.03
0.08
3.7
8.8
—
61.5
u/ml
—
0
23
11
98
1.12
0.07
1.4
1.5
—
—
—
0
0
16
174
0.92
0.07
1.1
1.2
—
—
—
0
0
8
76
1.05
0.07
1.0
1.0
—
—
—
0
0
9
85
1.06
0.07
1.2
1.1
—
—
—
0
0
9
85
1.06
0.07
1.2
1.1
—
—
—
0
0
9
86
1.05
0.07
1.0
1.2
—
—
—
0
0
9
86
1.05
0.07
1.2
1.1
—
—
—
0
0
9
86
1.05
0.07
1.2
1.1
—
—
—
0
0
9
86
1.05
0.07
1.2
1.1
—
—
—
0
0
9
87
1.03
0.07
1.0
1.2
—
—
—
0
0
8
90
0.89
0.06
1.0
1.6
9.7
12.1
umol/l
—
8
85
12
132
0.91
0.06
1.8
1.4
—
—
—
0
0
15
162
0.93
0.06
1.1
1.1
—
—
—
0
0
16
171
0.93
0.05
1.1
1.1
—
—
—
0
0
19
179
1.06
0.05
1.9
1.5
—
—
—
0
0
28
291
0.96
0.04
1.1
1.1
—
—
—
0
0
28
290
0.96
0.03
1.1
1.1
—
—
—
0
0
46
449
1.03
0.03
1.2
1.1
—
1.0
—
0
5
20
192
1.04
0.02
1.8
1.5
—
—
—
0
0
45
441
1.02
0.02
1.3
1.3
219.7
221.2
miu/ml
0.01
23
220
18
173
1.04
0.01
1.2
1.2
1.4
4.2
u/ml
—
5
58
17
177
0.96
0.01
1.0
1.0
1.9
2.4
u/ml
—
8
86
10
94
1.06
0.01
1.1
1.1
—
—
—
0
0
12
114
1.05
0.00
2.5
3.0
0.9
0.8
nmol/l
0.24
12
89
10
96
1.04
0.00
1.1
1.5
16.0
12.6
mmol/l
—
5
22
870
8696
1.00
0.00
17.0
12.4
13.6
13.5
%
0.81
856
8497
20
197
1.02
0.00
2.9
3.4
27.4
24.8
mg/l
—
8
131
13
125
1.04
0.00
1.2
1.1
101.0
95.2
%
0.32
13
117
5
58
0.86
0.00
1.0
1.3
27.8
35.3
nmol/l
—
5
49
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
0.00
0.0
1.3
—
7.8
—
0
9
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
16
160
1.00
0.00
1.4
1.2
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
8.0
—
0
5
6
69
0.87
0.00
2.3
1.2
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
9
99
0.91
0.00
1.2
1.4
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
23
230
1.00
0.00
1.5
1.3
858.6
2283.8
e6/l
0.46
18
188
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
6
69
0.87
0.00
2.3
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
2.6
—
23.0
—
0
7
6
66
0.91
0.00
3.7
1.3
—
—
—
0
0
9
94
0.96
0.00
1.8
1.4
—
—
—
0
0
7
69
1.01
0.00
1.1
1.3
—
—
—
0
0
0
8
0.00
0.00
0.0
3.0
—
—
—
0
0
0
5
0.00
0.00
0.0
3.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
23
230
1.00
0.00
1.4
1.3
12.7
26.6
e6/l
0.37
16
182
5
59
0.85
0.00
2.0
2.1
—
—
—
0
0
6
69
0.87
0.00
2.3
1.2
—
—
—
0
0
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_BENIGN_BONE_LONG_LOWER_EXALLC – Benign neoplasm: Long bones of lower limb
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).